| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | France | 3 | |
| #3 | Australia | 2 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Microorganisms | |
| #4 | Sugars | |
| #5 | Analysing materials | |
| #6 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Morel Alain | 7 |
| #2 | Gamelin Erick | 7 |
| #3 | Gauduchon Pascal | 6 |
| #4 | Poulain Laurent | 6 |
| #5 | Boisdron-Celle Michele | 5 |
| #6 | Gamelin Laurence | 4 |
| #7 | Saison-Behmoaras Ester | 4 |
| #8 | Brotin Emilie | 4 |
| #9 | Erbacher Patrick | 2 |
| #10 | Staedel Cathy | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2008001156A1 | CANCER THERAPY USING BcI-XL-SPECIFIC siNA | |
| FR2884257A1 | Prevention of toxicities due to 5-fluorouracile | |
| FR2834641A1 | PROTECTION OF NEUROTOXICITY OF OXALIPLATIN BY ADMINISTRATION OF CALCIUM AND MAGNESIUM | |
| FR2826869A1 | PRODUCTS SUITABLE TO TREAT OVARIAN CANCERS AND PREVENT RELAPSES |